2 results
Approved WMOCompleted
The AlphaCore* is currently being used in some hospitalised COPD subjects, as adjunctive treatment to regular care. This use is conform CE and is showing diminished breathlessness in some subjects. For further investigation of these results, this…
Approved WMOPending
The primary objective is to determine the survival rate after two and five years in fixed bearing Oxford lateral PKR with an uncemented femoral component and present patient reported outcome measures (PROMS), range of motion, radiographic findings…